0001127602-14-027195.txt : 20140904 0001127602-14-027195.hdr.sgml : 20140904 20140904162113 ACCESSION NUMBER: 0001127602-14-027195 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140902 FILED AS OF DATE: 20140904 DATE AS OF CHANGE: 20140904 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bollag Daniel M CENTRAL INDEX KEY: 0001461612 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36172 FILM NUMBER: 141083456 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS, INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2014-09-02 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001461612 Bollag Daniel M C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 Sr. VP, Reg. Affairs & Quality Common Stock 2014-09-02 4 M 0 26250 1.30 A 179705 D Common Stock 2014-09-02 4 S 0 26250 6.2176 D 153455 D Common Stock 2014-09-02 4 S 0 30400 6.2176 D 123055 D Employee Stock Option (Right to Buy) 1.30 2014-09-02 4 M 0 26250 0 D 2009-03-10 Common Stock 26250 11250 D Shares were acquired upon the exercise of outstanding stock options at $1.30 per share. This sale was pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.14 to $6.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote. Options vest 25% per year on each March 10, 2010, 2011, 2012 and 2013. /s/Edward M. Fitzgerald, Attorney-in-Fact 2014-09-04